IE
IE · IE · IE-PA-EU/1/09/577/1-4
Foclivia
ATC J07BB02
Last synced from HPRA (Ireland) on
Identification
ManufacturerSeqirus S.r.l.
CountryIE (IE)
ATC codeJ07BB02
Dispensing—
ReimbursedNo
SourceHPRA (Ireland)
Last synced6/8/2026
Packs · 1
- ie_pa_numberEU/1/09/577/1-4
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Suspension for injection",
"routes": [
"Intramuscular use"
],
"source": "hpra",
"atc_all": [
"J07BB",
"J07BB02"
],
"strength": null,
"pa_number": "EU/1/09/577/1-4",
"substances": [
"A/vietnam/1194/2004 (h5n1) virus surface inactivated antigen"
],
"legal_basis": "Informed consent application (Article 10c of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": null,
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}Related drugs
Other records sharing ATC code J07BB02.
- BEAdjupanrixGlaxoSmithKline Biologicals
- FIAdjupanrixGlaxoSmithKline Biologicals SA
- PLAdjupanrixGlaxoSmithKline Biologicals S.A.
- ISAdjupanrixGlaxoSmithKline Biologicals S.A.*
- DKAdjupanrixGlaxoSmithKline Biologicals S.A.
- CZADJUPANRIXGlaxoSmithKline Biologicals S.A., Rixensart
- IEAdjupanrix suspension and emulsion for emulsion for injection. Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)GlaxoSmithKline Biologicals S.A.
- NLAdjupanrix, (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals, suspensie en emulsie voor emulsie voor injectieGlaxoSmithKline Biologicals S.A.
Access this data programmatically
Query Foclivia and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.